December 9, 2020
On December 9, Travere Therapeutics held a virtual R&D day to review the company’s key pipeline programs. The event featured presentations from external experts and the Travere Therapeutics senior management team.
Watch the recorded webcast >
© 2021 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.
Terms and Conditions | Privacy Policies | Cookie Settings